TG Therapeutics, Inc.(TGTX)

$33.53▼-0.05 (-0.15%)

TG Therapeutics, Inc.(TGTX)

NASDAQ

$33.53▼-0.05 (-0.15%)

Overview Intelligence Chart Fundamentals Key Metrics Earnings Growth Analysts Financials Insiders Institutional

Analyst Sentiment

Analysts lean bullish — 85% recommend buying.

Consensus Rating

Buy

13 analysts·Moderate coverage

85%

Rating Distribution

Strong Buy

00%

Buy

1185%

Hold

18%

Sell

18%

Strong Sell

00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see significant upside — consensus target 48% higher.

Bear Case

$39.00

+16%

Consensus

$49.50

+48%

Bull Case

$60.00

+79%

Price Range13 analysts

Low

Consensus

High

$39.00

$60.00

Current Target

Current Price

$33.53

Upside to Target

$15.97

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)

FY2027

Rev+26.62%

EPS+64.66%

FY2028

Rev+28.16%

EPS+25.28%

FY2029

Rev+21.01%

EPS+13.20%

Earnings Surprises

Recent Analyst Actions

Jan 15, 2026Goldman Sachs

TG Therapeutics price target raised to $39 from $37 at Goldman Sachs

Target:$39.00

+32.0%from $29.54

Oct 6, 2025H.C. Wainwright

TG Therapeutics assumed with a Buy at H.C. Wainwright

Target:$60.00

+63.5%from $36.70

Nov 5, 2024H.C. Wainwright

TG Therapeutics (TGTX) PT Raised to $55 at H.C. Wainwright

Target:$55.00

+325.4%from $12.93

Aug 6, 2024Goldman Sachs

TG Therapeutics price target raised to $20 from $18 at Goldman Sachs

Target:$20.00

-2.8%from $20.58

May 3, 2024H.C. Wainwright

TG Therapeutics (TGTX) PT Raised to $49 at H.C. Wainwright

Target:$49.00

+496.8%from $8.21

Feb 7, 2023Cantor Fitzgerald

Cantor Fitzgerald Maintains Overweight on TG Therapeutics, Raises Price Target to $24

Target:$24.00

+29.9%from $18.48

Dec 30, 2022Evercore ISI

Evercore ISI Group Maintains Outperform on TG Therapeutics, Raises Price Target to $16

Target:$16.00

+35.2%from $11.83

Dec 29, 2022H.C. Wainwright

TG Therapeutics price target raised to $24 from $19 at H.C. Wainwright

Target:$24.00

+467.4%from $4.23

Apr 19, 2022Goldman Sachs

Goldman Sachs Maintains Sell on TG Therapeutics, Lowers Price Target to $5

Target:$5.00

-31.1%from $7.26

Apr 18, 2022Telsey Advisory

Has TG Therapeutics Stock Hit Bottom? Looking for the Silver Lining

Target:$23.00

+564.7%from $3.46

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance